Novavax seeks WHO approval for Covid jab - RTHK
A A A
Temperature Humidity
News Archive Can search within past 12 months

Novavax seeks WHO approval for Covid jab

2021-09-23 HKT 22:43
Share this story facebook
  • Novavax's jab was found to have high efficacy in trials in the US and Mexico. File image: AFP
    Novavax's jab was found to have high efficacy in trials in the US and Mexico. File image: AFP
Novavax and its partner the Serum Institute of India have applied to the World Health Organisation for an emergency use listing of Novavax's Covid-19 vaccine, the company said on Thursday.

The WHO's emergency use listing is a signal to national regulatory authorities on a product's safety and efficacy.

It is also a prerequisite for export to several countries participating in the Covax vaccine sharing facility.

Novavax and Serum Institute, the world's largest vaccine producer, have committed to together provide more than 1.1 billion doses to the Covax facility, which aims to provide equitable access to Covid-19 vaccines to low- and middle-income countries.

The Novavax shot is a protein-based vaccine, and has shown 90.4 percent efficacy overall in trials in the United States and Mexico. (Reuters)